Cargando…
厄洛替尼治疗脑脊液检测EGFR敏感突变的肺腺癌一例
BACKGROUND AND OBJECTIVE: One of the most ofen distance metastasis site of non-small cell lung cancer (NSCLC) is brain and the standard treatment of brain metastasis was radiotheraphy including whole brain irradiation (WBI) and stereotactic radiotherapy (SRT). It has been reported that epidermal gro...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999803/ https://www.ncbi.nlm.nih.gov/pubmed/26805738 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.01.07 |
Ejemplares similares
-
厄洛替尼致间质性肺病4例并文献复习
Publicado: (2012) -
帕博利珠单抗联合安罗替尼四线治疗EGFR基因敏感突变阳性肺腺癌1例
Publicado: (2021) -
安罗替尼治疗KRAS突变型晚期肺腺癌1例
Publicado: (2018) -
晚期EGFR突变型非小细胞肺癌患者接受吉非替尼或厄洛替尼治疗的成本效益分析
Publicado: (2013) -
厄洛替尼100 mg/天治疗化疗后进展的晚期肺腺癌的临床研究
Publicado: (2011)